AIA
MRVI icon

Alera Investment Advisors’s Maravai LifeSciences MRVI Stock Holding History

Alera Investment Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$86.9K Buy
+10,452
New +$90.4K 0.01% 288

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Alera Investment Advisors's MRVI Position: Q3 2024 in Review

Alera Investment Advisors opened a new position in Maravai LifeSciences (MRVI) in Q3 2024: 10,452 shares worth $86.9K. The stake represents 0.01% of the portfolio and ranks #288 among its holdings.

217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

  • Alera Investment Advisors held 10,452 shares of Maravai LifeSciences worth $86.9K as of Q3 2024.
  • Maravai LifeSciences was a new Alera Investment Advisors position in Q3 2024.
  • Maravai LifeSciences made up 0.01% of Alera Investment Advisors's portfolio in Q3 2024, its #288 holding.
  • 217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on Alera Investment Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.